Hung-Tsung Wu

Article

Prothymosin-α overexpression contributes to the development of insulin resistance

Su, Y. C., Ou, H. Y., Wu, H. T., Wu, P., Chen, Y. C., Su, B. H., Shiau, A. L., Chang, C. J. & Wu, C. L., 2015 11月, 於: Journal of Clinical Endocrinology and Metabolism. 100, 11, p. 4114-4123 10 p.

研究成果: Article › 同行評審

開啟存取

10 引文斯高帕斯（Scopus）

Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma

Kuo, H. Y., Han, M. Z., Liao, C. H., Lin, Y. J., Wang, C. T., Chen, S. H., Chang, T. T., Chen, P. J., Lin, S. H., Chen, C. Y., Chuang, C. H., Wu, I. C., Wu, J. S., Hong, T. C., Hsieh, M. T., Lee, Y. C., Wu, H. T. & Tsai, H. M., 2022 11月, 於: Pharmaceutics. 14, 11, 2263.

研究成果: Article › 同行評審

開啟存取

Real-World Comparative Evaluation of Add-On Glucagon-like Peptide 1 Receptor Agonist in Type 2 Diabetes Treated with or without Insulin

Chou, H. W., Cheng, K. P., Lin, A. C., Hung, H. C., Lin, C. H., Wang, C. C., Wu, H. T. & Ou, H. Y., 2022 12月, 於: Pharmaceuticals. 15, 12, 1569.

研究成果: Article › 同行評審

開啟存取

Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma

Chiang, H. C., Lee, Y. C., Chang, T. T., Lin, Y. J., Wu, H. T., Wang, C. T., Chen, C. Y., Chen, P. J., Hsieh, M. T., Lin, S. H., Chen, S. H., Chuang, C. H., Wu, I. C., Hong, T. C., Wu, J. S., Han, M. Z., Chen, W. T., Chiang, C. M., Hung, K. K. & Kuo, H. Y., 2023 2月, 於: Cancers. 15, 3, 854.

研究成果: Article › 同行評審

開啟存取

Rilmenidine improves hepatic steatosis through p38-dependent pathway to higher the expression of farnesoid X receptor

Yang, P. S., Wu, H. T., Chung, H. H., Chen, C. T., Chi, C. W., Yeh, C. H. & Cheng, J. T., 2012 1月, 於: Naunyn-Schmiedeberg's Archives of Pharmacology. 385, 1, p. 51-56 6 p.

研究成果: Article › 同行評審

6 引文斯高帕斯（Scopus）

Role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the action of ginsenoside Rh2 against beta-amyloid-induced inhibition of rat brain astrocytes

Shieh, P. C., Tsao, C. W., Li, J. S., Wu, H. T., Wen, Y. J., Kou, D. H. & Cheng, J. T., 2008 3月 21, 於: Neuroscience Letters. 434, 1, p. 1-5 5 p.

研究成果: Article › 同行評審

35 引文斯高帕斯（Scopus）

Role of placental fibrinogen-like protein 1 in gestational diabetes

Kang, L., Li, H. Y., Ou, H. Y., Wu, P., Wang, S. H., Chang, C-J., Lin, S. Y., Wu, C. L. & Wu, H. T., 2020 4月, 於: Translational Research. 218, p. 73-80 8 p.

研究成果: Article › 同行評審

14 引文斯高帕斯（Scopus）

Secretory autophagy promotes RAB37-mediated insulin secretion under glucose stimulation both in vitro and in vivo

Wu, S. Y., Wu, H. T., Wang, Y. C., Chang, C. J., Shan, Y. S., Wu, S. R., Chiu, Y. C., Hsu, C. L., Juan, H. F., Lan, K. Y., Chu, C. W., Lee, Y. R., Lan, S. H. & Liu, H. S., 2022, (Accepted/In press) 於: Autophagy.

研究成果: Article › 同行評審

開啟存取

2 引文斯高帕斯（Scopus）

Serum Angiopoietin-like Protein 6, Risk of Type 2 Diabetes, and Response to Hyperglycemia: A prospective cohort study

Fan, K. C., Wu, H. T., Wei, J. N., Chuang, L. M., Hsu, C. Y., Yen, I. W., Lin, C. H., Lin, M. S., Shih, S. R., Wang, S. H., Chang, T. J. & Li, H. Y., 2020 5月 1, 於: Journal of Clinical Endocrinology and Metabolism. 105, 5, dgaa103.

研究成果: Article › 同行評審

5 引文斯高帕斯（Scopus）

Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes

Ou, H. Y., Yang, Y. C., Wu, H. T., Wu, J. S., Lu, F. H. & Chang, C-J., 2011 10月, 於: Clinical Endocrinology. 75, 4, p. 450-455 6 p.

研究成果: Article › 同行評審

55 引文斯高帕斯（Scopus）

Serum secretogranin III concentrations were increased in subjects with metabolic syndrome and independently associated with fasting plasma glucose levels

Lin, C. C., Cheng, K. P., Hung, H. C., Li, C. H., Lin, C. H., Chang, C. J., Hu, C. Y., Wu, H. T. & Ou, H. Y., 2019 9月, 於: Journal of Clinical Medicine. 8, 9, 1436.

研究成果: Article › 同行評審

開啟存取

2 引文斯高帕斯（Scopus）

Serum vascular adhesion protein-1 is up-regulated in hyperglycemia and is associated with incident diabetes negatively

Kuo, C. H., Wei, J. N., Yang, C. Y., Ou, H. Y., Wu, H. T., Fan, K. C., Wang, S. H., Hua, C. H., Hsiao, C. H., Lee, M. K. & Li, H. Y., 2019 3月 1, 於: International Journal of Obesity. 43, 3, p. 512-522 11 p.

研究成果: Article › 同行評審

11 引文斯高帕斯（Scopus）

Stimulatory effect of stevioside on peripheral mu opioid receptors in animals

Yang, P. S., Lee, J. J., Tsao, C. W., Wu, H. T. & Cheng, J. T., 2009 4月 17, 於: Neuroscience Letters. 454, 1, p. 72-75 4 p.

研究成果: Article › 同行評審

19 引文斯高帕斯（Scopus）

Sucralose, a Non-nutritive Artificial Sweetener Exacerbates High Fat Diet-Induced Hepatic Steatosis Through Taste Receptor Type 1 Member 3

Wu, H. T., Lin, C. H., Pai, H. L., Chen, Y. C., Cheng, K. P., Kuo, H. Y., Li, C. H. & Ou, H. Y., 2022 5月 23, 於: Frontiers in Nutrition. 9, 823723.

研究成果: Article › 同行評審

開啟存取

3 引文斯高帕斯（Scopus）

Targeting fibrinogen-like protein 1 is a novel therapeutic strategy to combat obesity

Wu, H. T., Chen, S. C., Fan, K. C., Kuo, C. H., Lin, S. Y., Wang, S. H., Chang, C. J. & Li, H. Y., 2020 2月 1, 於: FASEB Journal. 34, 2, p. 2958-2967 10 p.

研究成果: Article › 同行評審

19 引文斯高帕斯（Scopus）

The acid sphingomyelinase inhibitors block interferon-α-induced serotonin uptake via a COX-2/Akt/ERK/STAT-dependent pathway in T cells

Su, H. C., Ma, C. T., Lin, C. F., Wu, H. T., Chuang, Y. H., Chen, L. J. & Tsao, C. W., 2011 11月, 於: International Immunopharmacology. 11, 11, p. 1823-1831 9 p.

研究成果: Article › 同行評審

9 引文斯高帕斯（Scopus）

The hepatic protection effects of hepassocin in hyperglycemic crisis

Ou, H. Y., Wu, H. T., Lin, C. H., Du, Y. F., Hu, C. Y., Hung, H. C., Wu, P., Li, H. Y., Wang, S. H. & Chang, C. J., 2017 7月 1, 於: Journal of Clinical Endocrinology and Metabolism. 102, 7, p. 2407-2415 9 p.

研究成果: Article › 同行評審

開啟存取

15 引文斯高帕斯（Scopus）

The role of Hepassocin in the development of non-alcoholic fatty liver disease

Wu, H. T., Lu, F. H., Ou, H. Y., Su, Y. C., Hung, H. C., Wu, J. S., Yang, Y. C., Wu, C. L. & Chang, C-J., 2013 11月, 於: Journal of Hepatology. 59, 5, p. 1065-1072 8 p.

研究成果: Article › 同行評審

56 引文斯高帕斯（Scopus）

The serum concentrations of hedgehog-interacting protein, a novel biomarker, were decreased in overweight or obese subjects

Chou, H. W., Hung, H. C., Lin, C. H., Lin, A. C., Du, Y. F., Cheng, K. P., Li, C. H., Chang, C. J., Wu, H. T. & Ou, H. Y., 2021 2月 2, 於: Journal of Clinical Medicine. 10, 4, p. 1-8 8 p., 742.

研究成果: Article › 同行評審

開啟存取

2 引文斯高帕斯（Scopus）

Unsaturated Fatty Acids Increase the Expression of Hepassocin through a Signal Transducer and Activator of Transcription 3-Dependent Pathway in HepG2 Cells

Cheng, K. P., Ou, H. Y., Hung, H. C., Li, C. H., Fan, K. C., Wu, J. S., Wu, H. T. & Chang, C-J., 2018 9月, 於: Lipids. 53, 9, p. 863-869 7 p.

研究成果: Article › 同行評審

8 引文斯高帕斯（Scopus）

吳 泓璁

研究成果

搜尋結果

吳泓璁